Study: Abdominoplasty Patients Find Pain Relief with Xaracoll Implant
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Among abdominoplasty patients receiving Xaracoll, a reduction in pain intensity and opioid use was observed through 24 hours post-surgery.
Galderma has launched FACE by Galderma, an aesthetic visualization tool powered by augmented reality that allows aesthetic professionals and patients to visualize injectable treatment results at the planning stage before treatment begins.